The program aims to improve detection, understand individual differences within the spectrum, and develop more personalized care approaches.
Washington, D.C. – The U.S. Department of Health and Human
Services (HHS) launched SPECTRA, a new research initiative designed to
transform how autism is understood, diagnosed, and treated throughout the
lifespan.
The program, developed by the Advanced Research Projects
Agency for Health (ARPA-H), will combine biological, clinical, behavioral, and
real-world data with advanced computational tools to find methods for earlier
and more accurate autism detection.
HHS Secretary Robert F. Kennedy Jr. said the initiative aims
to leverage American science and innovation to find better answers for people
with autism and their families.
“Autism is not the same for everyone, and neither should our
science and care,” Kennedy said in announcing the program.
SPECTRA considers the analysis of genetic, environmental,
familial, metabolic, immunological, and developmental factors to identify
different health and developmental trajectories among individuals on the
spectrum.
The program will also use computational models and
artificial intelligence platforms with privacy protection mechanisms to study
these trajectories and identify modifiable factors to improve outcomes.
Another objective is to develop tools that allow for the
selection and evaluation of individualized interventions, as well as to create
accessible technologies that can facilitate communication and improve quality
of life.
According to HHS, SPECTRA is structured around four main
areas: analysis, modeling, precision intervention, and enabling technologies.
